Streetbeat News

Equity Actions

EAT

Stifel analyst Chris O'Cull has upgraded Brinker International (NYSE:EAT) from Hold to Buy and raised the price target from $38 to $45.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 10:15 am

META

During an interview at Vox Media’s Code 2023 conference, Linda Yaccarino, the CEO of X (formerly Twitter), inadvertently revealed that the X app was not on her iPhone Home Screen. Instead, apps like Facebook and Instagram, owned by Meta Platforms Inc., were featured prominently. This comes amidst controversies surrounding X, including major layoffs, since Elon Musk's acquisition of the company.

Portfolio Pulse from Ananya Gairola

September 29, 2023 | 10:08 am

LCID

RIVN

Electric vehicle (EV) startups Rivian Automotive, Inc. (NASDAQ:RIVN) and Lucid Group, Inc. (NASDAQ:LCID) have struggled with production ramp-up and stock price performance over the past year. However, data suggests potential for improvement. A $100 investment in Rivian a year ago is currently worth $71.43, while the same investment in Lucid would be worth $38.97. Despite these losses, analysts are hopeful for a rebound, particularly as oversold levels provide a platform for potential growth. Rivian's stock rose 0.13% to $23.08 and Lucid's gained 1.28% to close at $5.53.

Portfolio Pulse from Shanthi Rexaline

September 29, 2023 | 9:20 am

ALV

Autoliv has retired over 1.23 million of its repurchased common shares, leaving approximately 84.15 million shares remaining outstanding.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 8:02 am

ANL

Adlai Nortye has priced its initial public offering (IPO) of 2.5 million American Depositary Shares (ADS) at $23 per ADS.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 7:27 am

MDGL

Madrigal Pharmaceuticals has priced its public offering at $151.69 per share for 1,248,098 common shares and $151.6899 per pre-funded warrant for 2,048,098 warrants, raising a total of $500 million.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 7:20 am

VCNX

Vaccinex has announced a public offering of 9.6 million common shares and warrants at $1 per share. The offering includes significant participation from an entity affiliated with the Chairman of the Company's Board of Directors, and existing investors. The warrants will have an exercise price of $1.00 per share, will be immediately exercisable and will expire five years from the initial exercise date.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 7:07 am

TNXP

Tonix Pharmaceuticals has priced a public offering of 9 million common shares and warrants at $0.50 per share. The offering includes Series A and Series B warrants, exercisable immediately, with an exercise price of $0.50 per share. The closing of the public offering is expected on October 3, 2023.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 7:03 am

OPRA

Opera has priced its secondary public offering of 6,876,506 American Depositary Shares at $12.25 per share.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 6:54 am

SWKH

SWK Holdings has priced a public offering of $30 million of 9.00% senior notes due 2027.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 6:41 am